Search Results - "Sinnige, LGF"

Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis by Toorop, Alyssa A, van Kempen, Zoé L E, Steenhuis, Maurice, Nielsen, Jessica, Sinnige, L G F, van Dijk, Gert, Roosendaal, Christiaan M, Arnoldus, Edo P J, Hoitsma, Elske, Lissenberg-Witte, Birgit I, de Jong, Brigit A, Oosten, Bob W van, Strijbis, Eva M M, Uitdehaag, Bernard M J, Rispens, Theo, Killestein, Joep, Arnoldus, EPJ, Barkhof, F, Bouvy, WH, van Dijk, GW, van Eijk, JJJ, Eurelings, M, van Genugten, J, Hoitsma, E, Hoogervorst, ELJ, de Jong, BA, Kalkers, NF, van Kempen, ZLE, Killestein, J, Kloosterziel, ME, Kragt, JJ, Lierop, ZYGJ. van, Lissenberg-Witte, BI, Moraal, B, Mostert, JP, van Munster, CEP, Nielsen, J, van Oosten, BW, Rispens, T, van Rooij, LC, Roosendaal, CM, Sinnige, LGF, Strijbis, EMM, Toorop, AA, Uitdehaag, BMJ, Vennegoor, A, Wokke, BHA, Zeinstra, EMPE

“…BackgroundNatalizumab is effective in the treatment of multiple sclerosis (MS). In 2021, the European Medicines Agency approved the subcutaneous (SC) variant…”
Get full text

Serum neurofilament light and glial fibrillary acidic protein levels are not associated with wearing-off symptoms in natalizumab-treated multiple sclerosis patients by Toorop, Alyssa A, Wessels, Mark HJ, Boonkamp, Lynn, Gelissen, Liza MY, Hoitsma, E, Zeinstra, Esther MPE, van Rooij, Luuk C, van Munster, Caspar EP, Vennegoor, Anke, Mostert, Jop P, Wokke, Beatrijs HA, Kalkers, Nynke F, Hoogervorst, Erwin LJ, van Eijk, Jeroen JJ, Roosendaal, Christiaan M, Kragt, Jolijn J, Eurelings, Marijke, van Genugten, Jessie, Nielsen, Jessica, Sinnige, LGF, Kloosterziel, Mark E, Arnoldus, Edo PJ, van Dijk, Gert W, Bouvy, Willem H, Strijbis, Eva MM, van Oosten, Bob W, de Jong, Brigit A, Uitdehaag, Bernard MJ, Rispens, Theo, Killestein, Joep, van Kempen, Zoé LE, Teunissen, Charlotte E

“…Background: Biomarkers of neuronal and axonal damage (serum neurofilament light (sNfL) and serum glial fibrillary acidic protein (sGFAP)) may provide insight…”
Get full text

An Unusual Cause of Neonatal Seizures in a Newborn Infant by de Klerk, O. L, de Vries, T. W, Sinnige, L. G. F

“…Neonatal seizures in the neonatal period are symptoms of numerous underlying disorders of the neonate. We present a case in which neonatal seizures due to…”
Get full text

Liver function disturbances in Guillain-Barré syndrome : a prospective longitudinal study in 100 patients by OOMES, P. G, VAN DER MECHE, F. G. A, KLEYWEG, R. P

Get full text

Hashimoto encephalopathy in a 12-year-old girl by Sybesma, C A, v Pinxteren-Nagler, E, Sinnige, L G, van Oostrom, J C, de Vries, T W

Get full text

Cobalt-55 positron emission tomography in relapsing-progressive multiple sclerosis by Jansen, H.M.L., Willemsen, A.T.M., Sinnige, L.G.F., Paans, A.M.J., Hew, J.M., Franssen, E.J.F., Zorgdrager, A.M., Pruim, J., Minderhoud, J.M., Korf, J.

“…Multiple sclerosis (MS) is an immune-mediated disease of the white matter in the brain that can have a progressive course. However, the progression of…”
Get full text

Regional specific changes of cerebral metabolism in systemic lupus erythematosus identified by positron emission tomography by de Jong, B M, Pruim, J, Sinnige, L G, Beintema, K D, Spronk, P E, Bootsma, H, Kallenberg, C G, van Zomeren, A H, Haaxma-Reiche, H

“…In order to test the hypothesis whether the pathogenesis of cerebral systemic lupus erythematosus (SLE) may include an immune-mediated deficit in specific…”
Get more information

Tuberculous meningitis in native Dutch children : a report of four cases by HOOIJBOER, P. G. A, VAN DER VLIET, A. M, SINNIGE, L. G. F

“…Although it is believed that in the western countries tuberculosis is a disease confined to high-risk groups such as immigrants, we describe four cases of…”
Get full text

Correlation between magnetic resonance imaging and clinical parameters in multiple sclerosis by Sinnige, L G, Teeuwissen, E, Hew, J M, Minderhoud, J M

“…In this study, the course of 60 consecutive multiple sclerosis patients (relapsing-remitting (RR), relapsing-progressive (RP), primary-progressive (PP)) was…”
Get more information

Is acyclovir prophylaxis necessary after bone marrow transplantation? by Sinnige, LGF, van der Meer, JWM, Gratama, J W, Versteeg, J, Zwaan, F E

“…To assess the cost-effect relationship of aciclovir prophylaxis versus early treatment, the authors performed a retrospective study in 44 allogeneic bone…”
Get full text

Marrow donor immunity to herpes simplex virus: association with acute graft-versus-host disease by Gratama, J W, Sinnige, L G, Weijers, T F, Zwaan, F E, van Heugten, J G, Stijnen, T, D'Amaro, J, The, T H, Hekker, A C, de Gast, G C

“…The interactions between humoral and cellular immunity to herpes simplex virus (HSV) in bone marrow donors, the occurrence of active HSV infections, and the…”
Get more information

Cytomegalovirus immunity in allogeneic marrow grafting by Gratama, J W, Middeldorp, J M, Sinnige, L G, van der Meer, J W, D'Amaro, J, Jansen, J, Zwaan, F E, Brand, A, de Gast, G C, The, T H

“…IgM and IgG class antibodies to cytomegalovirus (CMV) late antigen were studied in 58 bone marrow transplant (BMT) recipients and their donors using a…”
Get more information